Biofilms in chronic wounds and the potential role of negative pressure wound therapy: An integrative review

Journal of Wound, Ostomy and Continence Nursing

Volumn 40, Issue 2, 2013, Pages 143-149

  Bradley, Beth Hawkins ^a   Cunningham, Muriel ^b  

^a Clinical Education   (United States)

^b NONE

Author keywords

biofilms; chronic wounds; negative pressure wound therapy

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; BIOFILM; DEBRIDEMENT; HUMAN; INJURY; LAVAGE; MICROBIOLOGY; VACUUM ASSISTED CLOSURE;

ANTI-INFECTIVE AGENTS; BIOFILMS; DEBRIDEMENT; HUMANS; NEGATIVE-PRESSURE WOUND THERAPY; THERAPEUTIC IRRIGATION; WOUNDS AND INJURIES;

EID: 84875232134     PISSN: 10715754     EISSN: None     Source Type: Journal    
DOI: 10.1097/WON.0b013e31827e8481     Document Type: Article

References (76)

1. Montana State University Center for Biofilm Engineering Biofilm Basics. http://www2.erc.montana.edu/node/2408. Accessed August 20, 2010.
2. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001; 7 (2): 277-281.
3. Dunne WM Jr. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev. 2002; 15 (2): 155-166.
4. Hansen SK, Rainey PB, Haagensen JA, Molin S. Evolution of species interactions in a biofilm community. Nature. 2007; 445 (7127): 533-536.
5. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen. 2008; 16 (1): 23-29.
6. Jabra-Rizk MA, Falkler W A, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis. 2004; 10 (1): 14-19.
7. Suci PA, Mittelman MW, Yu FP, Geesey GG. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa bio-films. Antimicrob Agents Chemother. 1994; 38 (9): 2125-2133.
8. Flemming HC, Neu TR, Wozniak DJ. The EPS matrix: the "house of biofilm cells." J Bacteriol. 2007; 189 (22): 7945-7947.
9. Rupp CJ, Fux CA, Stoodley P. Viscoelasticity of Staphylococcus aureus biofilms in response to fluid shear allows resistance to detachment and facilitates rolling migration. Appl Environ Microbiol. 2005; 71 (4): 2175-2178.
10. Westgate SJ, Percival SL, Knottenbelt DC, Clegg PD, Cochrane CA. Chronic equine wounds: what is the role of infection and biofilms? Wounds. 2010; 6: 138.
11. Murray TS, Egan M, Kazmierczak BI. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients. Curr Opin Pediatr. 2007; 19 (1): 83-88.
12. Rogan MP, Taggart CC, Greene CM, Murphy PG, O'Neill SJ, McElvaney NG. Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. J Infect Dis. 2004; 190 (7): 1245-1253.
13. Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. J Intern Med. 1997; 242 (1): 15-22.
14. Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006; 296 (2): 202-211.
15. Garcia-Castillo M, Morosini MI, Galvez M, Baquero F, del Campo R, Meseguer MA. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urea-lyticum and Ureaplasma parvum isolates. J Antimicrob Chemother. 2008; 62 (5): 1027-1030.
16. Suh JD, Ramakrishnan V, Palmer JN. Biofilms. Otolaryngol Clin North Am. 2010; 43 (3): 521-530, viii.
17. Morgan SD, Rigby D, Stickler DJ. A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters. Urol Res. 2009; 37 (2): 89-93.
18. Marrie TJ, Costerton JW. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol. 1984; 19 (5): 687-693.
19. Behlau I, Gilmore MS. Microbial biofilms in ophthalmology and infectious disease. Arch Ophthalmol. 2008; 126 (11): 1572-1581.
20. Ehrlich GD, Stoodley P, Kathju S, et al. Engineering approaches for the detection and control of orthopaedic biofilm infections. Clin Orthop Relat Res. 2005 (437): 59-66.
21. Bernard L, Hoffmeyer P, Assal M, Vaudaux P, Schrenzel J, Lew D. Trends in the treatment of orthopaedic prosthetic infections. J Antimicrob Chemother. 2004; 53 (2): 127-129.
22. Litzler PY, Benard L, Barbier-Frebourg N, et al. Biofilm formation on pyrolytic carbon heart valves: influence of surface free energy, roughness, and bacterial species. J Thorac Cardiovasc Surg. 2007; 134 (4): 1025-1032.
23. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004; 187 (5A): 65S-70S.
24. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008; 16 (1): 37-44.
25. Hurlow J, Bowler PG. Clinical experience with wound biofilm and management: a case series. Ostomy Wound Manage. 2009; 55 (4): 38-49.
26. Wolcott RD, Rhoads DD, Dowd SE. Biofilms and chronic wound inflammation. J Wound Care. 2008; 17 (8): 333-341.
27. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007; 117 (5): 1219-1222.
28. Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am. 2007; 21 (3): 617-638, vii.
29. Gontcharova V, Youn E, Sun Y, Wolcott RD, Dowd SE. A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol J. 2010; 4: 8-19.
30. Wolcott RD, Rhoads DD. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care. 2008; 17 (4): 145-148, 150-142, 154-145.
31. Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J. 2006; 3 (3): 225-231.
32. Dowd SE, Sun Y, Secor PR, et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribo-some shotgun sequencing. BMC Microbiol. 2008; 8: 43.
33. Kirketerp-Moller K, Jensen PO, Fazli M, et al. Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol. 2008; 46 (8): 2717-2722.
34. Fisher TK, Wolcott R, Wolk DM, Bharara M, Kimbriel HR, Armstrong DG. Diabetic foot infections: a need for innovative assessments. Int J Low Extrem Wounds. 2010; 9 (1): 31-36.
35. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg. 2003; 29 (6): 631-635.
36. Wolcott RD, Rumbaugh KP, James G, et al. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care. 2010; 19 (8): 320-328.
37. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15 (2): 167-193.
38. Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science. 2006; 311 (5764): 1113-1116.
39. Njoroge J, Sperandio V. Jamming bacterial communication: new approaches for the treatment of infectious diseases. EMBO Mol Med. 2009; 1 (4): 201-210.
40. Smith KM, Bu Y, Suga H. Induction and inhibition of Pseudomonas aeruginosa quorum sensing by synthetic autoin-ducer analogs. Chem Biol. 2003; 10 (1): 81-89.
41. Swem LR, Swem DL, O'Loughlin CT, et al. A quorum-sensing antagonist targets both membrane-bound and cytoplasmic receptors and controls bacterial pathogenicity. Mol Cell. 2009; 35 (2): 143-153.
42. O'May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW. Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol. 2009; 58 (Pt 6): 765-773.
43. Ammons MC, Ward LS, Fisher ST, Wolcott RD, James GA. In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lacto-ferrin and xylitol. Int J Antimicrob Agents. 2009; 33 (3): 230-236.
44. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature. 2002; 417 (6888): 552-555.
45. Baldoni D, Steinhuber A, Zimmerli W, Trampuz A. In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods. Antimicrob Agents Chemother. 2010; 54 (1): 157-163.
46. Banin E, Lozinski A, Brady KM, et al. The potential of desferri-oxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc Natl Acad Sci U S A. 2008; 105 (43): 16761-16766.
47. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest. 2007; 117 (4): 877-888.
48. Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination. J Antimicrob Chemother. 2009; 64 (1): 88-93.
49. Itoh Y, Wang X, Hinnebusch BJ, Preston JF III, Romeo T. Depolymerization of beta-1, 6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol. 2005; 187 (1): 382-387.
50. Alandejani T, Marsan J, Ferris W, Slinger R, Chan F. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Otolaryngol Head Neck Surg. 2009; 141 (1): 114-118.
51. Merckoll P, Jonassen TO, Vad ME, Jeansson SL, Melby KK. Bacteria, biofilm and honey: a study of the effects of honey on "planktonic" and biofilm-embedded chronic wound bacteria. Scand J Infect Dis. 2009; 41 (5): 341-347.
52. Badet C, Furiga A, Thebaud N. Effect of xylitol on an in vitro model of oral biofilm. Oral Health Prev Dent. 2008; 6 (4): 337-341.
53. Wolcott RD, Kennedy JP, Dowd SE. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care. 2009; 18 (2): 54-56.
54. Giovinco NA, Bui TD, Fisher T, Mills JL, Armstrong DG. Wound chemotherapy by the use of negative pressure wound therapy and infusion. Eplasty. 2010; 10: e9.
55. Vikatmaa P, Juutilainen V, Kuukasjarvi P, Malmivaara A. Negative pressure wound therapy: a systematic review on effectiveness and safety. Eur J Vasc Endovasc Surg. 2008; 36 (4): 438-448.
56. Wolvos T. Wound instillation the next step in negative pressure wound therapy. Lessons learned from initial experiences. Ostomy Wound Manage. 2004; 50 (11): 56-66.
57. Arnljots B, Svedman P. Irrigation treatment in split-thickness skin grafting of intractable leg ulcers. Scand J Plast Reconstr Surg. 1985; 19: 211-213.
58. Svedman P. Irrigation treatment of leg ulcers. The Lancet. 1983; 3: 532-534.
59. Svedman P, Sanden G, Arnljots B, Banck G. A dressing system providing fluid supply and suction drainage used for continuous or intermittent irrigation. Ann Plast Surg. 1986; 17 (2): 125-133.
60. Svedman PA. A dressing allowing continuous treatment of a biosurface. ICRS Med Sci Biomed Technol. 1979; 7: 221.
61. Joseph E, Hamori C, Bergman S, Roaf E, Swann N, Anastasi G. A prospective randomized trial of vacuum-assisted closure versus standard therapy of chronic non-healing wounds. Wounds. 2000; 12 (3): 60-67.
62. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997; 38 (6): 563-576; discussion 577.
63. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997; 38 (6): 553-562.
64. McCallon SK, Knight CA, Valiulus JP, Cunningham MW, McCulloch JM, Farinas LP. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage. 2000; 46 (8): 28-32, 34.
65. Jerome D. Advances in negative pressure wound therapy: the VAC instill. J Wound Ostomy Continence Nurs. 2007; 34 (2): 191-194.
66. Svedman P, Sanden G, Arnljots B, Banck G. A dressing system providing fluid supply and suction drainage used for continuous or intermittent irrigation. Ann Plast Surg. 1986; 17 (2): 125-133.
67. Teder H, Sanden G, Svedman P. Continuous wound irrigation in the pig. J Invest Surg. 1990; 3: 399-407.
68. Innovative Therapies Inc. Web site. Svedman Wound Treatment System User's Manual. Rev 1, July 2009. http://itimedical.com/manual/SvedmanManual.pdf. Accessed December 1, 2012.
69. Kinetic Concepts Inc. Web site. V.A.C. Instill System Brochure. http://www.kci1.com/KCI1/vactherapyformsandbrochures. Accessed August 19, 2010.
70. Svedman P, Ljungh A, Rausing A, et al. Staphylococcal wound infection in the pig: Part I. Course. Ann Plast Surg. 1989; 23: 212-218.
71. Sanden G, Ljungh A, Wadstrom T, Banck G, Miedzobrodski J, Svedman P. Staphylococcal wound infection in the pig: Part II. Inoculation, quantification of bacteria, and reproducibility. Ann Plast Surg. 1989; 23: 219-223.
72. Scimeca CL, Bharara M, Fisher TK, Giovinco N, Armstrong DG. Novel use of doxycycline in continuous-instillation negative pressure wound therapy as "wound chemotherapy." Foot Ankle Spec. 2010; 3 (4): 190-193.
73. Zelen CM, Stover B, Nielson D, Cunningham M. A prospective study of negative pressure wound therapy with integrated irrigation for the treatment of diabetic foot ulcers. Eplasty 2011: e5.
74. Gabriel A, Shores J, Heinrich C, et al. Negative pressure wound therapy with instillation: a pilot study describing a new method for treating infected wounds. Int Wound J. 2008; 5 (3): 399-413.
75. Raad W, Lantis JC II, Tyrie L, Gendics C, Todd G. Vacuum-assisted closure instill as a method of sterilizing massive venous stasis wounds prior to split thickness skin graft placement. Int Wound J. 2010; 7 (2): 81-85.
76. Timmers MS, Graafland N, Bernards AT, Nelissen RG, van Dissel JT, Jukema GN. Negative pressure wound treatment with polyvinyl alcohol foam and polyhexanide antiseptic solution instillation in posttraumatic osteomyelitis. Wound Repair Regen. 2009; 17 (2): 278-286.